1,572 results on '"Shi, Pei Yong"'
Search Results
202. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
203. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
204. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
205. Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
206. Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD
207. A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
208. Infection Kinetics and Transmissibility of a Reanimated Dengue Virus Serotype 4 Identified Originally in Wild Aedes aegypti From Florida
209. BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants
210. Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
211. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
212. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection
213. The search for nucleoside/nucleotide analog inhibitors of dengue virus
214. The dengue virus NS5 protein as a target for drug discovery
215. Stabilization of dengue virus polymerase in de novo initiation assay provides advantages for compound screening
216. Targeting dengue virus NS4B protein for drug discovery
217. A small molecule fusion inhibitor of dengue virus
218. Antiviral effect of interferon lambda against West Nile virus
219. Identification and characterization of inhibitors of West Nile virus
220. Noninvasive bioluminescence imaging of dengue virus infection in the brain of A129 mice
221. Author response: Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
222. Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells
223. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
224. Rational design of West Nile virus vaccine through large replacement of 3′ UTR with internal poly(A)
225. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
226. One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
227. Ecology and transmission of a dengue virus serotype 4 identified in wild Aedes aegypti in Florida
228. Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area
229. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
230. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
231. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
232. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
233. An Interview with Pei-Yong Shi, PhD
234. Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain
235. Additional file 1 of Zika virus induces neuronal and vascular degeneration in developing mouse retina
236. Flavivirus methyltransferase: A novel antiviral target
237. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
238. Flavivirus RNA cap methyltransferase: structure, function, and inhibition
239. Crystal structure of dengue virus methyltransferase without S-adenosyl-L-methionine
240. Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580
241. Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors
242. Unraveling a Flavivirus Enigma
243. Live attenuated vaccine: the first clinically approved dengue vaccine?
244. A virus-type specific serological diagnosis of flavivirus infection using virus-like particles
245. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
246. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
247. Zika virus induces neuronal and vascular degeneration in developing mouse retina
248. Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited sera
249. Glucosidase inhibitors suppress SARS-CoV-2 in tissue culture and may potentiate
250. CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.